General Information of the Compound
Compound ID
CP0074148
Compound Name
5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1-one
    Show/Hide
Synonyms
1(2H)-Isoquinolinone, 5,8-dichloro-2-((1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl)-3,4-dihydro-7-((R)-methoxy-3-oxetanylmethyl)-
1844849-10-0
5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one
5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1-one
BDBM50246967
CHEMBL4080228
CJD
CS-0092626
DB14799
GTPL10516
HY-101571A
NSC-800019
NSC800019
PF-06821497
PF06821497
Q29209799
S4L4MM20B6
SCHEMBL17330426
UNII-S4L4MM20B6
compound 23a [PMID: 29211475]
    Show/Hide
Structure
Formula
C22H24Cl2N2O5
Molecular Weight
467.349
Canonical SMILES
CO[C@H](C1COC1)c1cc(Cl)c2CCN(Cc3c(OC)cc(C)[nH]c3=O)C(=O)c2c1Cl
    Show/Hide
InChI
InChI=1S/C22H24Cl2N2O5/c1-11-6-17(29-2)15(21(27)25-11)8-26-5-4-13-16(23)7-14(19(24)18(13)22(26)28)20(30-3)12-9-31-10-12/h6-7,12,20H,4-5,8-10H2,1-3H3,(H,25,27)/t20-/m1/s1
    Show/Hide
InChIKey
RXCVUHMIWHRLDF-HXUWFJFHSA-N
CAS
1844849-10-0
Physicochemical Property
logP
3.53112
Rotatable Bonds
6
Heavy Atom Count
31
Polar Areas
80.86
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
31

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118572065
ChEMBL ID
CHEMBL4080228
DrugBank ID
DB14799
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03003, Histone-lysine N-methyltransferase EZH2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000180 Karpas-422 Homo sapiens (Human)  1
1
IC50 = 4 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki < 0.1 nM
Clinical Information about the Compound
Drug 1 ( PF-06821497 )
Drug Name PF-06821497
Company Pfizer
Indication
Small-cell lung cancer
Phase 1
Follicular lymphoma
Phase 1
Prostate cancer
Phase 1
Diffuse large B-cell lymphoma
Phase 1
Small-cell lung cancer
Phase 1
Target(s)
Enhancer of zeste homolog 2 (EZH2)
Inhibitor